Fluorescent Nanoparticles for the Guided Surgery of Ovarian Peritoneal Carcinomatosis
Nanomaterials, 2018 Complete surgical resection is the ideal cure for ovarian peritoneal carcinomatosis, but remains challenging. Fluorescent guided surgery can be a promising approach for precise cytoreduction when appropriate fluorophore is used. In the presence paper, we
Tristan Mangeolle +6 more
doaj +1 more source
Florid diffuse peritoneal deciduosis mimicking carcinomatosis in a primigravida patient: A case report and review of the literature [PDF]
, 2013 A case of a 27 year old G1P0 female with a dichorionic, diamniotic twin pregnancy presenting with premature rupture of membranes found to have omental caking and diffuse yellow-tan peritoneal nodules, clinically suspicious for carcinomatosis.
Adhikari, Laura J, Shen, Rulong
core +2 more sources
Peritoneal carcinosis of ovarian origin [PDF]
, 2010 Epithelial ovarian cancer (EOC) is the second most common genital malignancy in women and is the most lethal gynecological malignancy, with an estimated five-year survival rate of 39%.
Fagotti, A +7 more
core +2 more sources
Diffuse malignant peritoneal mesothelioma mimicking ovarian cancer.
Radiology Case Reports, 2022 Diffuse malignant peritoneal mesothelioma (DMPM) and peritoneal carcinomatosis have similar computed tomography imaging features. Peritoneal carcinomatosis is a known metastatic site for many malignancies and particularly gastrointestinal tract and ...
Zaynab Iraqi Houssaini, Intern in radiology +7 more
doaj
Intraperitoneal chemotherapy for gastric cancer with peritoneal carcinomatosis: is HIPEC the only answer? [PDF]
, 2014 Gastric cancer with peritoneal carcinomatosis is notorious for its dismal prognosis. While the pathophysiology of peritoneal dissemination is still controversial, the rapid downhill course is universal.
Kwong, DLW, Lam, KO, Law, BTT, Law, SYK
core +1 more source
Molecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Peritoneal Tuberculosis (? Carcinomatosis) [PDF]
Mayo Clinic Proceedings, 2006 Ashok K. Malani, Jayant Rao
openaire +3 more sources
Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer. [PDF]
, 2015 The objective of this study was to evaluate the correlation between 25-OH vitamin D and ovarian cancer as a diagnostic marker or recurrence disease marker.
Anastasi, Emanuela +6 more
core +1 more source
Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
Anticancer Research, 2018 Although systemic chemotherapy has been improved, peritoneal carcinomatosis remains a factor of poor prognosis in patients with colorectal cancer. In order to achieve a higher drug concentration in the peritoneal cavity, intraperitoneal chemotherapy has ...
K. Murono +9 more
semanticscholar +1 more source
The next steps in improving the outcomes of advanced ovarian cancer [PDF]
, 2015 Worldwide ovarian cancer affects over 200,000 women per year. Overall survival rates are poor due to two predominate reasons. First, the majority of patients present with advanced disease creating significant difficulty with effecting disease eradication.
Blagden, S +3 more
core +1 more source